KEGG   PATHWAY: lruf05200
Entry
lruf05200                   Pathway                                
Name
Pathways in cancer - Lynx rufus (bobcat)
Class
Human Diseases; Cancer: overview
Pathway map
lruf05200  Pathways in cancer
lruf05200

Organism
Lynx rufus (bobcat) [GN:lruf]
Gene
124517028  netrin receptor DCC [KO:K06765]
124520277  caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
124514692  caspase-9-like [KO:K04399] [EC:3.4.22.62]
124524439  DCC-interacting protein 13-alpha [KO:K08733]
124510761  cadherin-1 [KO:K05689]
124510785  LOW QUALITY PROTEIN: cadherin-1-like [KO:K05689]
124526000  catenin beta-1 [KO:K02105]
124503525  catenin alpha-2 isoform X1 [KO:K05691]
124505812  catenin alpha-3 [KO:K05691]
124516204  catenin alpha-1 [KO:K05691]
124525491  axin-1 isoform X1 [KO:K02157]
124513498  axin-2 [KO:K04385]
124519809  adenomatous polyposis coli protein isoform X1 [KO:K02085]
124527684  adenomatous polyposis coli protein 2-like isoform X1 [KO:K02085]
124526728  glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
124515627  transcription factor 7 isoform X1 [KO:K02620]
124503502  transcription factor 7-like 1 [KO:K04490]
124507146  transcription factor 7-like 2 isoform X1 [KO:K04491]
124520997  lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
124513356  baculoviral IAP repeat-containing protein 5 isoform X1 [KO:K08731]
124507805  myc proto-oncogene protein [KO:K04377]
124506147  G1/S-specific cyclin-D1 [KO:K04503]
124501222  proto-oncogene Wnt-1 [KO:K03209]
124524767  protein Wnt-2 [KO:K00182]
124514758  protein Wnt-2b [KO:K00182]
124512838  proto-oncogene Wnt-3 [KO:K00312]
124520203  protein Wnt-3a [KO:K00312]
124514394  protein Wnt-4 [KO:K00408]
124524797  protein Wnt-5a [KO:K00444]
124502605  protein Wnt-5b [KO:K00444]
124514572  protein Wnt-6 [KO:K00445]
124501047  protein Wnt-7b [KO:K00572]
124522850  protein Wnt-7a [KO:K00572]
124506283  protein Wnt-8b [KO:K00714]
124509477  protein Wnt-8a [KO:K00714]
124512797  protein Wnt-9b [KO:K01064]
124520256  protein Wnt-9a [KO:K01064]
124514501  LOW QUALITY PROTEIN: protein Wnt-10a-like [KO:K01357]
124500979  protein Wnt-10b [KO:K01357]
124504623  protein Wnt-11 [KO:K01384]
124523223  protein Wnt-16 [KO:K01558]
124524898  frizzled-1 [KO:K02432]
124516209  frizzled-7 [KO:K02432]
124522257  frizzled-2 [KO:K02235]
124520701  frizzled-3 [KO:K02329]
124505762  frizzled-4 [KO:K02354]
124501774  LOW QUALITY PROTEIN: frizzled-8-like [KO:K02375]
124515634  frizzled-5 [KO:K02375]
124519080  frizzled-6 [KO:K02376]
124519329  frizzled-9 [KO:K02842]
124522028  frizzled-10 [KO:K02842]
124504910  low-density lipoprotein receptor-related protein 5 [KO:K03068]
124501748  low-density lipoprotein receptor-related protein 6 [KO:K03068]
124526346  segment polarity protein dishevelled homolog DVL-3 [KO:K02353]
124519481  segment polarity protein dishevelled homolog DVL-2 isoform X1 [KO:K02353]
124514972  segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
124507027  proto-oncogene FRAT1-like [KO:K03069]
124507028  GSK-3-binding protein FRAT2-like [KO:K03096]
124505518  prothrombin [KO:K01313] [EC:3.4.21.5]
124518614  angiotensinogen-like [KO:K09821]
124518259  proteinase-activated receptor 1-like [KO:K03914]
124523882  proteinase-activated receptor 4-like isoform X1 [KO:K04236]
124502841  lysophosphatidic acid receptor 1 [KO:K04289]
124524552  lysophosphatidic acid receptor 2 [KO:K04291]
124514634  lysophosphatidic acid receptor 3 [KO:K04294]
124509171  lysophosphatidic acid receptor 4 [KO:K04275]
124501374  lysophosphatidic acid receptor 5-like [KO:K08390]
124512258  lysophosphatidic acid receptor 6 [KO:K04273]
124526985  type-1 angiotensin II receptor [KO:K04166]
124519214  guanine nucleotide-binding protein subunit alpha-12 [KO:K04346]
124513497  guanine nucleotide-binding protein subunit alpha-13 [KO:K04639]
124504834  rho guanine nucleotide exchange factor 12 isoform X1 [KO:K07532]
124521741  rho guanine nucleotide exchange factor 11-like isoform X1 [KO:K12331]
124511074  rho guanine nucleotide exchange factor 1 isoform X1 [KO:K12330]
124515703  pleckstrin homology domain-containing family G member 5 isoform X1 [KO:K19464]
124523904  transforming protein RhoA [KO:K04513]
124517572  rho-associated protein kinase 1 isoform X1 [KO:K04514] [EC:2.7.11.1]
124504219  rho-associated protein kinase 2 [KO:K17388] [EC:2.7.11.1]
124506687  stromal cell-derived factor 1 isoform X1 [KO:K10031]
124515642  C-X-C chemokine receptor type 4 [KO:K04189]
124514443  guanine nucleotide-binding protein G(i) subunit alpha-3 [KO:K04630]
124523010  guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630]
124524167  guanine nucleotide-binding protein G(i) subunit alpha-1 isoform X1 [KO:K04630]
124523241  prostaglandin E2 receptor EP1 subtype [KO:K04258]
124512192  prostaglandin E2 receptor EP2 subtype [KO:K04259]
124516345  prostaglandin E2 receptor EP3 subtype isoform X1 [KO:K04260]
124522033  prostaglandin E2 receptor EP4 subtype [KO:K04261]
124503012  guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas isoform X1 [KO:K04632]
124503255  neuroendocrine secretory protein 55 [KO:K04632]
124524637  adenylate cyclase type 1 [KO:K08041] [EC:4.6.1.1]
124508049  adenylate cyclase type 2 [KO:K08042] [EC:4.6.1.1]
124503617  adenylate cyclase type 3 isoform X1 [KO:K08043] [EC:4.6.1.1]
124508863  adenylate cyclase type 4 isoform X1 [KO:K08044] [EC:4.6.1.1]
124526579  adenylate cyclase type 5 [KO:K08045] [EC:4.6.1.1]
124501854  adenylate cyclase type 6 isoform X1 [KO:K08046] [EC:4.6.1.1]
124511307  adenylate cyclase type 7 isoform X1 [KO:K08047] [EC:4.6.1.1]
124507481  adenylate cyclase type 8 [KO:K08048] [EC:4.6.1.1]
124517827  adenylate cyclase type 9 [KO:K08049] [EC:4.6.1.1]
124514583  cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
124524048  cAMP-dependent protein kinase catalytic subunit alpha isoform X1 [KO:K04345] [EC:2.7.11.11]
124514958  guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 [KO:K04536]
124519383  guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 [KO:K04537]
124502071  guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 [KO:K07825]
124527017  guanine nucleotide-binding protein subunit beta-4 isoform X1 [KO:K04538]
124508581  guanine nucleotide-binding protein subunit beta-5 [KO:K04539]
124512197  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 [KO:K07826]
124504777  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3-like [KO:K04540]
124504946  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 [KO:K04540]
124518716  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 [KO:K04541]
124514905  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 [KO:K04542]
124524944  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 [KO:K04543]
124510994  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 [KO:K04544]
124503016  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 [KO:K04545]
124523593  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 [KO:K04546]
124516147  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 [KO:K04347]
124523582  putative guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-14 [KO:K04347]
124525585  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 [KO:K04547]
124522836  guanine nucleotide-binding protein G(T) subunit gamma-T1 [KO:K04548]
124513259  uncharacterized protein LOC124513259 isoform X1 [KO:K04549]
124513895  collagen alpha-5(IV) chain isoform X1 [KO:K06237]
124513959  collagen alpha-6(IV) chain-like [KO:K06237]
124515358  collagen alpha-4(IV) chain-like [KO:K06237]
124508764  collagen alpha-2(IV) chain [KO:K06237]
124516326  collagen alpha-3(IV) chain-like [KO:K06237]
124517053  collagen alpha-1(IV) chain [KO:K06237]
124519858  LOW QUALITY PROTEIN: laminin subunit alpha-1-like [KO:K05637]
124529086  laminin subunit alpha-2 [KO:K05637]
124503809  LOW QUALITY PROTEIN: laminin subunit alpha-5-like [KO:K06240]
124517646  laminin subunit alpha-3-like isoform X1 [KO:K06240]
124529047  laminin subunit alpha-4 isoform X1 [KO:K06241]
124524744  laminin subunit beta-1 [KO:K05636]
124524361  laminin subunit beta-2 [KO:K06243]
124510084  laminin subunit beta-3 isoform X1 [KO:K06244]
124524730  laminin subunit beta-4-like [KO:K06245]
124510147  laminin subunit gamma-1 [KO:K05635]
124510439  laminin subunit gamma-2 [KO:K06246]
124525641  laminin subunit gamma-3-like [KO:K06247]
124515423  fibronectin-like isoform X1 [KO:K05717]
124521689  integrin alpha-2 [KO:K06481]
124522131  integrin alpha-IIb-like [KO:K06476]
124513240  integrin alpha-3 [KO:K06482]
124516428  integrin alpha-6 isoform X1 [KO:K06485]
124515657  integrin alpha-V [KO:K06487]
124501220  integrin beta-1 [KO:K05719]
124507840  focal adhesion kinase 1 isoform X1 [KO:K05725] [EC:2.7.10.2]
124525968  phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
124527077  phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
124514827  phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
124517840  phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
124514527  phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649]
124523730  phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
124518602  phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
124520457  homeobox protein Nkx-3.1-like [KO:K09348]
124510270  RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
124511119  RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
124512474  RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
124507057  inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1 [KO:K04467] [EC:2.7.11.10]
124521298  inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
124525847  NF-kappa-B essential modulator isoform X1 [KO:K07210]
124508912  NF-kappa-B inhibitor alpha [KO:K04734]
124520800  nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
124507090  nuclear factor NF-kappa-B p100 subunit [KO:K04469]
124504954  transcription factor p65 [KO:K04735]
124510169  prostaglandin G/H synthase 2 [KO:K11987] [EC:1.14.99.1]
124513041  nitric oxide synthase, inducible [KO:K13241] [EC:1.14.13.39]
124517105  apoptosis regulator Bcl-2 [KO:K02161]
124504870  baculoviral IAP repeat-containing protein 2 [KO:K16060]
124506366  baculoviral IAP repeat-containing protein 3-like [KO:K16060]
124513901  E3 ubiquitin-protein ligase XIAP isoform X1 [KO:K04725] [EC:2.3.2.27]
124503234  baculoviral IAP repeat-containing protein 7-like [KO:K16061]
124503169  bcl-2-like protein 1 isoform X1 [KO:K04570]
124503618  TNF receptor-associated factor 1 [KO:K03172]
124522349  TNF receptor-associated factor 2 [KO:K03173] [EC:2.3.2.27]
124512500  TNF receptor-associated factor 3 [KO:K03174]
124512882  TNF receptor-associated factor 4 [KO:K09848]
124510097  TNF receptor-associated factor 5 [KO:K09849]
124505383  TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
124514798  serine/threonine-protein kinase mTOR [KO:K07203] [EC:2.7.11.1]
124505103  ribosomal protein S6 kinase beta-2 isoform X1 [KO:K04688] [EC:2.7.11.1]
124513164  ribosomal protein S6 kinase beta-1 isoform X1 [KO:K04688] [EC:2.7.11.1]
124505120  bcl2-associated agonist of cell death-like [KO:K02158]
124511738  forkhead box protein O1 [KO:K07201]
124501378  E3 ubiquitin-protein ligase Mdm2 isoform X1 [KO:K06643] [EC:2.3.2.27]
124519563  cellular tumor antigen p53 isoform X1 [KO:K04451]
124500999  cyclin-dependent kinase inhibitor 1B [KO:K06624]
124528296  cyclin-dependent kinase inhibitor 1 [KO:K06625]
124518162  breakpoint cluster region protein isoform X1 [KO:K08878] [EC:2.7.11.1]
124525633  tyrosine-protein kinase ABL1 [KO:K06619] [EC:2.7.10.2]
124519825  crk-like protein [KO:K04438]
124512970  adapter molecule crk isoform X1 [KO:K04438]
124504852  E3 ubiquitin-protein ligase CBL [KO:K04707] [EC:2.3.2.27]
124522097  signal transducer and activator of transcription 5A isoform X1 [KO:K11223]
124522246  signal transducer and activator of transcription 5B isoform X1 [KO:K11224]
124528336  serine/threonine-protein kinase pim-1 [KO:K04702] [EC:2.7.11.1]
124509521  serine/threonine-protein kinase pim-2 [KO:K08806] [EC:2.7.11.1]
124526765  kininogen-2-like isoform X1 [KO:K03898]
124528998  endothelin-1 [KO:K16366]
124512427  B1 bradykinin receptor-like [KO:K03915]
124512289  B2 bradykinin receptor-like [KO:K03916]
124520812  endothelin-1 receptor isoform X1 [KO:K04197]
124513142  endothelin receptor type B [KO:K04198]
124528694  guanine nucleotide-binding protein G(q) subunit alpha isoform X1 [KO:K04634]
124524235  guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
124503791  1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4-like [KO:K05858] [EC:3.1.4.11]
124503878  1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 [KO:K05858] [EC:3.1.4.11]
124505119  1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
124508712  1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
124513500  protein kinase C alpha type isoform X1 [KO:K02677] [EC:2.7.11.13]
124517730  protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
124527789  protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
124520662  interleukin-2 [KO:K05429]
124509424  interleukin-3-like [KO:K04736]
124523858  interleukin-4 [KO:K05430]
124523720  interleukin-5 [KO:K05428]
124524718  interleukin-6 [KO:K05405]
124507732  interleukin-7-like isoform X1 [KO:K05431]
124526682  interleukin-12 subunit alpha [KO:K05406]
124520689  interleukin-12 subunit beta [KO:K05425]
124523786  interleukin-13-like [KO:K05435]
124520617  interleukin-15 [KO:K05433]
124501368  interleukin-23 subunit alpha [KO:K05426]
124519180  erythropoietin [KO:K05437]
124524295  interferon alpha-like [KO:K05414]
124525665  interferon alpha-2-like [KO:K05414]
124525682  interferon alpha-2-like [KO:K05414]
124525697  interferon alpha [KO:K05414]
124525706  interferon alpha-like [KO:K05414]
124525727  interferon alpha-like [KO:K05414]
124502020  interferon gamma [KO:K04687]
124501580  interleukin-2 receptor subunit alpha [KO:K05068]
124501540  interleukin-2 receptor subunit beta-like [KO:K05069]
124521570  cytokine receptor common subunit gamma isoform X1 [KO:K05070]
124509311  interleukin-3 receptor subunit alpha-like isoform X1 [KO:K04737]
124517909  interleukin-4 receptor subunit alpha-like isoform X1 [KO:K05071]
124501643  cytokine receptor common subunit beta-like isoform X1 [KO:K04738]
124524268  interleukin-5 receptor subunit alpha-like [KO:K05067]
124521695  interleukin-6 receptor subunit alpha-like isoform X1 [KO:K05055]
124517290  interleukin-6 receptor subunit beta isoform X1 [KO:K05060]
124522249  interleukin-7 receptor subunit alpha-like isoform X1 [KO:K05072]
124523112  interleukin-12 receptor subunit beta-1-like isoform X1 [KO:K05063]
124514131  interleukin-12 receptor subunit beta-2-like isoform X1 [KO:K05064]
124513869  interleukin-13 receptor subunit alpha-1 [KO:K05076]
124516127  interleukin-23 receptor-like [KO:K05065]
124524413  erythropoietin receptor isoform X1 [KO:K05079]
124527044  interferon alpha/beta receptor 1-like [KO:K05130]
124525951  interferon alpha/beta receptor 2-like isoform X1 [KO:K05131]
124527922  interferon gamma receptor 1-like [KO:K05132]
124526582  interferon gamma receptor 2-like isoform X1 [KO:K05133]
124504120  echinoderm microtubule-associated protein-like 4 isoform X1 [KO:K15420]
124503580  ALK tyrosine kinase receptor [KO:K05119] [EC:2.7.10.1]
124508723  RAS guanyl-releasing protein 1 isoform X1 [KO:K04350]
124504875  RAS guanyl-releasing protein 2 isoform X1 [KO:K12361]
124503577  ras guanyl-releasing protein 3 isoform X1 [KO:K12362]
124511162  RAS guanyl-releasing protein 4 isoform X1 [KO:K12363]
124515396  tyrosine-protein kinase JAK1 [KO:K11217] [EC:2.7.10.2]
124527989  tyrosine-protein kinase JAK2 isoform X1 [KO:K04447] [EC:2.7.10.2]
124523034  tyrosine-protein kinase JAK3 isoform X1 [KO:K11218] [EC:2.7.10.2]
124522098  signal transducer and activator of transcription 3 isoform X1 [KO:K04692]
124515343  signal transducer and activator of transcription 1-alpha/beta [KO:K11220]
124501367  signal transducer and activator of transcription 2-like [KO:K11221]
124515342  signal transducer and activator of transcription 4 isoform X1 [KO:K11222]
124501154  signal transducer and activator of transcription 6 [KO:K11225]
124529172  uncharacterized protein LOC124529172 [KO:K05448]
124505127  vascular endothelial growth factor B isoform X1 [KO:K16858]
124512131  placenta growth factor-like isoform X1 [KO:K16859]
124520334  vascular endothelial growth factor C [KO:K05449]
124509365  vascular endothelial growth factor D [KO:K05449]
124503927  protransforming growth factor alpha [KO:K08774]
124520329  LOW QUALITY PROTEIN: pro-epidermal growth factor-like [KO:K04357]
124523868  epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
124513327  receptor tyrosine-protein kinase erbB-2 isoform X1 [KO:K05083] [EC:2.7.10.1]
124519341  platelet-derived growth factor subunit A isoform X1 [KO:K04359]
124502365  platelet-derived growth factor subunit B [KO:K17386]
124520247  platelet-derived growth factor receptor alpha isoform X1 [KO:K04363] [EC:2.7.10.1]
124507266  platelet-derived growth factor receptor beta isoform X1 [KO:K05089] [EC:2.7.10.1]
124502456  insulin-like growth factor I isoform X1 [KO:K05459]
124527882  insulin-like growth factor II [KO:K13769]
124517265  insulin-like growth factor 1 receptor isoform X1 [KO:K05087] [EC:2.7.10.1]
124502685  kit ligand [KO:K05461]
124520981  mast/stem cell growth factor receptor Kit [KO:K05091] [EC:2.7.10.1]
124510912  fms-related tyrosine kinase 3 ligand-like isoform X1 [KO:K05454]
124511181  receptor-type tyrosine-protein kinase FLT3 [KO:K05092] [EC:2.7.10.1]
124523080  hepatocyte growth factor isoform X1 [KO:K05460]
124524670  hepatocyte growth factor receptor [KO:K05099] [EC:2.7.10.1]
124517067  fibroblast growth factor 1 isoform X1 [KO:K18496]
124521134  LOW QUALITY PROTEIN: fibroblast growth factor 2-like [KO:K18497]
124510046  fibroblast growth factor 18 [KO:K04358]
124510963  fibroblast growth factor 9 [KO:K04358]
124504714  fibroblast growth factor 4 [KO:K04358]
124519959  fibroblast growth factor 5 isoform X1 [KO:K04358]
124506118  fibroblast growth factor 3-like [KO:K04358]
124527665  fibroblast growth factor 22-like [KO:K04358]
124506722  fibroblast growth factor 8 isoform X1 [KO:K04358]
124520853  fibroblast growth factor 20 [KO:K04358]
124520903  fibroblast growth factor 17 isoform X1 [KO:K04358]
124501069  fibroblast growth factor 6 [KO:K04358]
124507410  fibroblast growth factor 10 [KO:K04358]
124508605  fibroblast growth factor 7 [KO:K04358]
124509155  fibroblast growth factor 16 [KO:K04358]
124506117  fibroblast growth factor 19-like [KO:K22603]
124511571  fibroblast growth factor 21-like [KO:K22429]
124501214  fibroblast growth factor 23-like [KO:K22428]
124520453  LOW QUALITY PROTEIN: fibroblast growth factor receptor 1-like [KO:K04362] [EC:2.7.10.1]
124506756  LOW QUALITY PROTEIN: fibroblast growth factor receptor 2-like [KO:K05093] [EC:2.7.10.1]
124522669  fibroblast growth factor receptor 3 isoform X1 [KO:K05094] [EC:2.7.10.1]
124520052  fibroblast growth factor receptor 4 isoform X1 [KO:K05095] [EC:2.7.10.1]
124513422  growth factor receptor-bound protein 2 [KO:K04364]
124504040  son of sevenless homolog 1 isoform X1 [KO:K03099]
124512209  son of sevenless homolog 2 isoform X1 [KO:K03099]
124527565  GTPase HRas isoform X1 [KO:K02833]
124502703  GTPase KRas isoform X1 [KO:K07827]
124516245  GTPase NRas [KO:K07828]
124509491  serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
124524722  serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
124523760  RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
124508471  dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
124524782  dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
124517731  mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:2.7.11.24]
124519861  mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
124516273  transcription factor Jun [KO:K04448]
124512631  protein c-Fos [KO:K04379]
124506258  protein C-ets-1 isoform X1 [KO:K02678]
124504840  interstitial collagenase-like [KO:K01388] [EC:3.4.24.7]
124511320  72 kDa type IV collagenase [KO:K01398] [EC:3.4.24.24]
124503402  matrix metalloproteinase-9 [KO:K01403] [EC:3.4.24.35]
124520198  interleukin-8 [KO:K10030]
124501159  cyclin-dependent kinase 4 isoform X1 [KO:K02089] [EC:2.7.11.22]
124512574  ribosomal protein S6 kinase alpha-5 isoform X1 [KO:K04445] [EC:2.7.11.1]
124506146  proto-oncogene tyrosine-protein kinase receptor Ret [KO:K05126] [EC:2.7.10.1]
124506827  coiled-coil domain-containing protein 6 isoform X1 [KO:K09288]
124506961  nuclear receptor coactivator 4-like isoform X1 [KO:K09289]
124521817  high affinity nerve growth factor receptor isoform X1 [KO:K03176] [EC:2.7.10.1]
124521888  tropomyosin alpha-3 chain isoform X1 [KO:K09290]
124521247  LOW QUALITY PROTEIN: tropomyosin alpha-3 chain-like [KO:K09290]
124510165  nucleoprotein TPR isoform X1 [KO:K09291]
124526571  protein TFG isoform X1 [KO:K09292]
124523107  ras association domain-containing protein 1 isoform X1 [KO:K09850]
124509963  ras association domain-containing protein 5 isoform X1 [KO:K08015]
124503353  serine/threonine-protein kinase 4 isoform X1 [KO:K04411]
124529187  death-associated protein kinase 1 [KO:K08803] [EC:2.7.11.1]
124508517  death-associated protein kinase 2 isoform X1 [KO:K08803] [EC:2.7.11.1]
124523886  death-associated protein kinase 3 [KO:K08803] [EC:2.7.11.1]
124503060  1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
124511524  1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X1 [KO:K05859] [EC:3.1.4.11]
124509494  ETS domain-containing protein Elk-1 [KO:K04375]
124503379  calmodulin-1 [KO:K02183]
124510996  calmodulin-1 [KO:K02183]
124512578  calmodulin-1 [KO:K02183]
124514424  LOW QUALITY PROTEIN: calmodulin-like protein 6 [KO:K02183]
124508455  LOW QUALITY PROTEIN: calmodulin-like protein 4 [KO:K02183]
124502502  calmodulin-like protein 3 [KO:K02183]
124502628  calmodulin-like [KO:K02183]
124524655  calcium/calmodulin-dependent protein kinase type II subunit beta [KO:K04515] [EC:2.7.11.17]
124520612  calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1 [KO:K04515] [EC:2.7.11.17]
124506916  calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
124521364  calcium/calmodulin-dependent protein kinase type II subunit alpha-like [KO:K04515] [EC:2.7.11.17]
124503890  ral guanine nucleotide dissociation stimulator-like [KO:K08732]
124525632  ral guanine nucleotide dissociation stimulator isoform X1 [KO:K08732]
124523651  ras-related protein Ral-A [KO:K07834]
124514605  ras-related protein Ral-B [KO:K07835]
124519890  ralA-binding protein 1 isoform X1 [KO:K08773]
124519312  cell division control protein 42 homolog [KO:K04393]
124514573  cell division control protein 42 homolog [KO:K04393]
124519305  ras-related C3 botulinum toxin substrate 1 [KO:K04392]
124501030  ras-related C3 botulinum toxin substrate 2 isoform X1 [KO:K07860]
124522479  ras-related C3 botulinum toxin substrate 3-like [KO:K07861]
124525987  phospholipase D1 isoform X1 [KO:K01115] [EC:3.1.4.4]
124519573  phospholipase D2 isoform X1 [KO:K01115] [EC:3.1.4.4]
124520648  mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
124506951  mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
124514653  mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
124503598  paired box protein Pax-8 [KO:K09293]
124524538  peroxisome proliferator-activated receptor gamma [KO:K08530]
124522367  retinoic acid receptor RXR-alpha isoform X1 [KO:K08524]
124528137  retinoic acid receptor RXR-beta isoform X1 [KO:K08525]
124510372  retinoic acid receptor RXR-gamma [KO:K08526]
124527103  retinoic acid receptor beta isoform X1 [KO:K08528]
124529259  estrogen receptor [KO:K08550]
124512326  estrogen receptor beta isoform X1 [KO:K08551]
124503065  nuclear receptor coactivator 1 isoform X1 [KO:K09101] [EC:2.3.1.48]
124503159  nuclear receptor coactivator 3 isoform X1 [KO:K11256] [EC:2.3.1.48]
124502539  transcription factor Sp1 isoform X1 [KO:K04684]
124527932  peroxisome proliferator-activated receptor delta isoform X1 [KO:K04504]
124522235  junction plakoglobin [KO:K10056]
124505157  zinc finger and BTB domain-containing protein 16 [KO:K10055]
124513342  LOW QUALITY PROTEIN: retinoic acid receptor alpha-like [KO:K08527]
124520480  cyclin-A2 [KO:K06627]
124509481  cyclin-A1 [KO:K06627]
124508418  protein PML-like isoform X1 [KO:K10054] [EC:2.3.2.-]
124526329  runt-related transcription factor 1 isoform X1 [KO:K08367]
124519045  protein CBFA2T1 [KO:K10053]
124505642  transcription factor PU.1 isoform X1 [KO:K09438]
124511262  CCAAT/enhancer-binding protein alpha [KO:K09055]
124509310  granulocyte-macrophage colony-stimulating factor receptor subunit alpha-like [KO:K05066]
124509309  granulocyte-macrophage colony-stimulating factor receptor subunit alpha-like isoform X1 [KO:K05066]
124516500  granulocyte colony-stimulating factor receptor-like isoform X1 [KO:K05061]
124521466  macrophage colony-stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]
124525759  cyclin-dependent kinase inhibitor 2A-like isoform X1 [KO:K06621]
124503500  transcription factor E2F1 [KO:K17454]
124515072  transcription factor E2F2 isoform X1 [KO:K09389]
124528848  transcription factor E2F3 isoform X1 [KO:K06620]
124512113  protein max isoform X1 [KO:K04453]
124514675  zinc finger and BTB domain-containing protein 17 [KO:K10500]
124501072  cyclin-dependent kinase 4 inhibitor B [KO:K04685]
124523204  cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
124501054  G1/S-specific cyclin-D2 [KO:K10151]
124528816  G1/S-specific cyclin-D3 isoform X1 [KO:K10152]
124527676  cyclin-dependent kinases regulatory subunit 2 [KO:K02219]
124521874  cyclin-dependent kinases regulatory subunit 1 [KO:K02219]
124515676  S-phase kinase-associated protein 1 [KO:K03094]
124524656  cullin-1 [KO:K03347]
124501699  E3 ubiquitin-protein ligase RBX1 [KO:K03868] [EC:2.3.2.32]
124522217  S-phase kinase-associated protein 2 [KO:K03875]
124502320  cyclin-dependent kinase 2 isoform X1 [KO:K02206] [EC:2.7.11.22]
124511276  G1/S-specific cyclin-E1 isoform X1 [KO:K06626]
124518951  G1/S-specific cyclin-E2 [KO:K06626]
124512196  retinoblastoma-associated protein isoform X1 [KO:K06618]
124524872  growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
124515398  growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
124523614  growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
124510927  apoptosis regulator BAX isoform X1 [KO:K02159]
124528274  bcl-2 homologous antagonist/killer [KO:K14021]
124504922  DNA damage-binding protein 2 isoform X1 [KO:K10140]
124518196  DNA polymerase kappa-like isoform X1 [KO:K03511] [EC:2.7.7.7]
124522726  LOW QUALITY PROTEIN: telomerase reverse transcriptase-like [KO:K11126] [EC:2.7.7.49]
124523039  microphthalmia-associated transcription factor isoform X1 [KO:K09455]
124511094  transforming growth factor beta-1 proprotein isoform X1 [KO:K13375]
124510378  transforming growth factor beta-2 proprotein isoform X1 [KO:K13376]
124512625  transforming growth factor beta-3 proprotein [KO:K13377]
124502313  TGF-beta receptor type-1 isoform X1 [KO:K04674] [EC:2.7.11.30]
124526598  TGF-beta receptor type-2 isoform X1 [KO:K04388] [EC:2.7.11.30]
124517096  mothers against decapentaplegic homolog 2 isoform X1 [KO:K04500]
124508465  mothers against decapentaplegic homolog 3 isoform X1 [KO:K23605]
124516988  mothers against decapentaplegic homolog 4 isoform X1 [KO:K04501]
124526640  histone-lysine N-methyltransferase MECOM isoform X1 [KO:K04462] [EC:2.1.1.367]
124507216  C-terminal-binding protein 2 isoform X1 [KO:K04496] [EC:1.1.1.428]
124522633  C-terminal-binding protein 1 isoform X1 [KO:K04496] [EC:1.1.1.428]
124528271  histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]
124514885  histone deacetylase 1 isoform X1 [KO:K06067] [EC:3.5.1.98]
124526785  DNA mismatch repair protein Mlh1 [KO:K08734]
124504069  DNA mismatch repair protein Msh2 [KO:K08735]
124518549  DNA mismatch repair protein Msh3-like [KO:K08736]
124503151  DNA mismatch repair protein Msh6 [KO:K08737]
124511444  breast cancer type 2 susceptibility protein homolog [KO:K08775]
124508704  DNA repair protein RAD51 homolog 1 [KO:K04482]
124510216  tumor necrosis factor ligand superfamily member 6 [KO:K04389]
124518681  tumor necrosis factor receptor superfamily member 6-like [KO:K04390]
124505197  FAS-associated death domain protein-like [KO:K02373]
124515468  caspase-8-like [KO:K04398] [EC:3.4.22.61]
124501306  BH3-interacting domain death agonist-like [KO:K04726]
124517009  phorbol-12-myristate-13-acetate-induced protein 1-like [KO:K10131]
124510983  bcl-2-binding component 3, isoforms 1/2 isoform X1 [KO:K10132]
124503325  bcl-2-like protein 11 isoform X1 [KO:K16341]
124524650  cytochrome c [KO:K08738]
124526642  cytochrome c-like [KO:K08738]
124526919  cytochrome c-like [KO:K08738]
124514186  cytochrome c, testis-specific-like [KO:K08738]
124501505  cytochrome c-like [KO:K08738]
124502126  cytochrome c-like [KO:K08738]
124502711  apoptotic protease-activating factor 1 isoform X1 [KO:K02084]
124507150  caspase-7 isoform X1 [KO:K04397] [EC:3.4.22.60]
124523929  kelch-like ECH-associated protein 1 [KO:K10456]
124514555  nuclear factor erythroid 2-related factor 2 isoform X1 [KO:K05638]
124502305  heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]
124511446  NAD(P)H dehydrogenase [quinone] 1 [KO:K00355] [EC:1.6.5.2]
124518329  glutathione S-transferase theta-1-like [KO:K00799] [EC:2.5.1.18]
124518330  glutathione S-transferase theta-4-like [KO:K00799] [EC:2.5.1.18]
124518376  glutathione S-transferase theta-3-like isoform X1 [KO:K00799] [EC:2.5.1.18]
124518377  glutathione S-transferase theta-1 isoform X1 [KO:K00799] [EC:2.5.1.18]
124520489  microsomal glutathione S-transferase 2 [KO:K00799] [EC:2.5.1.18]
124506319  LOW QUALITY PROTEIN: glutathione S-transferase omega-2-like [KO:K00799] [EC:2.5.1.18]
124507125  glutathione S-transferase omega-1 [KO:K00799] [EC:2.5.1.18]
124528729  glutathione S-transferase A2 [KO:K00799] [EC:2.5.1.18]
124529260  glutathione S-transferase A4 isoform X1 [KO:K00799] [EC:2.5.1.18]
124529381  LOW QUALITY PROTEIN: glutathione S-transferase-like [KO:K00799] [EC:2.5.1.18]
124515811  glutathione S-transferase Mu 3 [KO:K00799] [EC:2.5.1.18]
124515940  glutathione S-transferase Mu 4-like isoform X1 [KO:K00799] [EC:2.5.1.18]
124502576  microsomal glutathione S-transferase 1 [KO:K00799] [EC:2.5.1.18]
124509923  microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]
124505671  glutathione S-transferase P [KO:K23790] [EC:2.5.1.18]
124525715  thioredoxin reductase 2, mitochondrial isoform X1 [KO:K22182] [EC:1.8.1.9]
124523368  thioredoxin reductase 3 [KO:K22182] [EC:1.8.1.9]
124502653  thioredoxin reductase 1, cytoplasmic [KO:K22182] [EC:1.8.1.9]
124524316  von Hippel-Lindau disease tumor suppressor [KO:K03871]
124507724  elongin-C [KO:K03872]
124528988  elongin-C-like [KO:K03872]
124517897  elongin-B isoform X1 [KO:K03873]
124506000  elongin-B-like [KO:K03873]
124516626  elongin-B-like [KO:K03873]
124501340  cullin-2 [KO:K03870]
124511105  prolyl hydroxylase EGLN2 isoform X1 [KO:K09592] [EC:1.14.11.29]
124518601  egl nine homolog 1 isoform X1 [KO:K09592] [EC:1.14.11.29]
124508892  prolyl hydroxylase EGLN3 [KO:K09592] [EC:1.14.11.29]
124510262  fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
124512137  hypoxia-inducible factor 1-alpha [KO:K08268]
124503773  endothelial PAS domain-containing protein 1 [KO:K09095]
124516159  aryl hydrocarbon receptor nuclear translocator isoform X1 [KO:K09097]
124517207  aryl hydrocarbon receptor nuclear translocator 2 isoform X1 [KO:K15589]
124517735  CREB-binding protein isoform X1 [KO:K04498] [EC:2.3.1.48]
124501617  histone acetyltransferase p300 [KO:K04498] [EC:2.3.1.48]
124515644  solute carrier family 2, facilitated glucose transporter member 1 [KO:K07299]
124503879  protein jagged-1 [KO:K06052]
124512327  protein jagged-2 isoform X1 [KO:K21635]
124511742  LOW QUALITY PROTEIN: delta-like protein 3 [KO:K06051]
124527837  delta-like protein 1 [KO:K06051]
124508251  delta-like protein 4 [KO:K06051]
124522322  LOW QUALITY PROTEIN: neurogenic locus notch homolog protein 1-like [KO:K02599]
124516604  neurogenic locus notch homolog protein 2 isoform X1 [KO:K20994]
124522904  neurogenic locus notch homolog protein 3 [KO:K20995]
124529032  neurogenic locus notch homolog protein 4 [KO:K20996]
124526288  transcription factor HES-1 [KO:K06054]
124514782  transcription factor HES-5 [KO:K06055]
124507432  hairy/enhancer-of-split related with YRPW motif protein 1 isoform X1 [KO:K09091]
124514860  hairy/enhancer-of-split related with YRPW motif-like protein [KO:K09091]
124528934  hairy/enhancer-of-split related with YRPW motif protein 2 [KO:K09091]
124509327  vascular endothelial growth factor receptor 3 [KO:K05097] [EC:2.7.10.1]
124523508  sonic hedgehog protein [KO:K11988]
124529241  protein patched homolog 1 [KO:K06225]
124525159  smoothened homolog [KO:K06226]
124517315  LOW QUALITY PROTEIN: kinesin-like protein KIF7 [KO:K18806]
124507098  suppressor of fused homolog isoform X1 [KO:K06229]
124501321  zinc finger protein GLI1 isoform X1 [KO:K16797]
124516485  zinc finger protein GLI2 [KO:K16798]
124524721  transcriptional activator GLI3 [KO:K06230]
124504345  bone morphogenetic protein 2 [KO:K21283]
124512337  bone morphogenetic protein 4 [KO:K04662]
124520992  hedgehog-interacting protein [KO:K06231]
124515976  protein patched homolog 2 isoform X1 [KO:K11101]
124521599  androgen receptor [KO:K08557]
124512510  heat shock protein HSP 90-alpha [KO:K04079]
124528527  heat shock protein HSP 90-beta [KO:K04079]
124501451  endoplasmin [KO:K09487]
Compound
C00027  Hydrogen peroxide
C00039  DNA
C00076  Calcium cation
C00122  Fumarate
C00149  (S)-Malate
C00165  Diacylglycerol
C00187  Cholesterol
C00280  Androstenedione
C00410  Progesterone
C00416  Phosphatidate
C00533  Nitric oxide
C00535  Testosterone
C00575  3',5'-Cyclic AMP
C00584  Prostaglandin E2
C00681  1-Acyl-sn-glycerol 3-phosphate
C00704  Superoxide
C00735  Cortisol
C00762  Cortisone
C00777  Retinoate
C00951  Estradiol-17beta
C01227  Dehydroepiandrosterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01471  Acrolein
C03917  Dihydrotestosterone
C05981  Phosphatidylinositol-3,4,5-trisphosphate
C07653  Flutamide
C15493  9-cis-Retinoic acid
C16038  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
C16844  Hydroxyl radical
C21641  Hydroperoxyl radical
C21642  4-Hydroxynonenal
Reference
  Authors
Weinberg RA.
  Title
The biology of cancer
  Journal
Garland Science, Taylor & Francis Group, LLC (2007)
Reference
  Authors
Hanahan D, Weinberg RA
  Title
The hallmarks of cancer.
  Journal
Cell 100:57-70 (2000)
DOI:10.1016/S0092-8674(00)81683-9
Reference
  Authors
Grady WM.
  Title
Genomic instability and colon cancer.
  Journal
Cancer Metastasis Rev 23:11-27 (2004)
DOI:10.1023/A:1025861527711
Reference
  Authors
Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.
  Title
Microsatellite instability in colorectal cancer.
  Journal
Br J Surg 93:395-406 (2006)
DOI:10.1002/bjs.5328
Reference
  Authors
Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.
  Title
Hereditary non-polyposis colorectal cancer: an updated review.
  Journal
Eur J Surg Oncol 26:635-45 (2000)
DOI:10.1053/ejso.2000.0974
Reference
  Authors
Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.
  Title
Colorectal cancer: genetics of development and metastasis.
  Journal
J Gastroenterol 41:185-92 (2006)
DOI:10.1007/s00535-006-1801-6
Reference
  Authors
Lynch HT, de la Chapelle A.
  Title
Hereditary colorectal cancer.
  Journal
N Engl J Med 348:919-32 (2003)
DOI:10.1056/NEJMra012242
Reference
  Authors
Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.
  Title
The significance of unstable chromosomes in colorectal cancer.
  Journal
Nat Rev Cancer 3:695-701 (2003)
DOI:10.1038/nrc1165
Reference
  Authors
Behrens J.
  Title
Cadherins and catenins: role in signal transduction and tumor progression.
  Journal
Cancer Metastasis Rev 18:15-30 (1999)
DOI:10.1023/A:1006200102166
Reference
  Authors
Behrens J.
  Title
The role of the Wnt signalling pathway in colorectal tumorigenesis.
  Journal
Biochem Soc Trans 33:672-5 (2005)
DOI:10.1042/BST0330672
Reference
  Authors
Behrens J, Lustig B.
  Title
The Wnt connection to tumorigenesis.
  Journal
Int J Dev Biol 48:477-87 (2004)
DOI:10.1387/ijdb.041815jb
Reference
PMID:9196022
  Authors
Polakis P.
  Title
The adenomatous polyposis coli (APC) tumor suppressor.
  Journal
Biochim Biophys Acta 1332:F127-47 (1997)
DOI:10.1016/S0304-419X(97)00008-5
Reference
  Authors
Janssen KP.
  Title
Murine models of colorectal cancer: studying the role of oncogenic K-ras.
  Journal
Cell Mol Life Sci 60:495-506 (2003)
DOI:10.1007/s000180300041
Reference
  Authors
Adjei AA.
  Title
Blocking oncogenic Ras signaling for cancer therapy.
  Journal
J Natl Cancer Inst 93:1062-74 (2001)
DOI:10.1093/jnci/93.14.1062
Reference
  Authors
Arakawa H.
  Title
Netrin-1 and its receptors in tumorigenesis.
  Journal
Nat Rev Cancer 4:978-87 (2004)
DOI:10.1038/nrc1504
Reference
  Authors
Mehlen P, Fearon ER.
  Title
Role of the dependence receptor DCC in colorectal cancer pathogenesis.
  Journal
J Clin Oncol 22:3420-8 (2004)
DOI:10.1200/JCO.2004.02.019
Reference
  Authors
Peltomaki P.
  Title
DNA mismatch repair and cancer.
  Journal
Mutat Res 488:77-85 (2001)
DOI:10.1016/S1383-5742(00)00058-2
Reference
  Authors
Li F, Cao Y, Townsend CM Jr, Ko TC.
  Title
TGF-beta signaling in colon cancer cells.
  Journal
World J Surg 29:306-11 (2005)
DOI:10.1007/s00268-004-7813-6
Reference
  Authors
Roman C, Saha D, Beauchamp R.
  Title
TGF-beta and colorectal carcinogenesis.
  Journal
Reference
  Authors
Watson AJ.
  Title
An overview of apoptosis and the prevention of colorectal cancer.
  Journal
Crit Rev Oncol Hematol 57:107-21 (2006)
DOI:10.1016/j.critrevonc.2005.06.005
Reference
  Authors
Watson AJ.
  Title
Apoptosis and colorectal cancer.
  Journal
Gut 53:1701-9 (2004)
DOI:10.1136/gut.2004.052704
Reference
  Authors
Houlston RS.
  Title
What we could do now: molecular pathology of colorectal cancer.
  Journal
Mol Pathol 54:206-14 (2001)
DOI:10.1136/mp.54.4.206
Reference
  Authors
Von Hoff D, Evans D, Hruban R (ed).
  Title
Pancreatic cancer
  Journal
Jones and Bartlett publishers (2005)
Reference
  Authors
Niitsu Y, Yokota J (ed).
  Title
[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)
  Journal
Nankodo (1999)
Reference
  Authors
Bardeesy N, DePinho RA.
  Title
Pancreatic cancer biology and genetics.
  Journal
Nat Rev Cancer 2:897-909 (2002)
DOI:10.1038/nrc949
Reference
  Authors
Bardeesy N, Sharpless NE, DePinho RA, Merlino G.
  Title
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.
  Journal
Semin Cancer Biol 11:201-18 (2001)
DOI:10.1006/scbi.2000.0371
Reference
  Authors
Cowgill SM, Muscarella P.
  Title
The genetics of pancreatic cancer.
  Journal
Am J Surg 186:279-86 (2003)
DOI:10.1016/S0002-9610(03)00226-5
Reference
  Authors
Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.
  Title
Genetics and biology of pancreatic ductal adenocarcinoma.
  Journal
Genes Dev 20:1218-49 (2006)
DOI:10.1101/gad.1415606
Reference
  Authors
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.
  Title
Understanding Ras: 'it ain't over 'til it's over'.
  Journal
Trends Cell Biol 10:147-54 (2000)
DOI:10.1016/S0962-8924(00)01740-2
Reference
  Authors
Holbro T, Civenni G, Hynes NE.
  Title
The ErbB receptors and their role in cancer progression.
  Journal
Exp Cell Res 284:99-110 (2003)
DOI:10.1016/S0014-4827(02)00099-X
Reference
  Authors
Marmor MD, Skaria KB, Yarden Y.
  Title
Signal transduction and oncogenesis by ErbB/HER receptors.
  Journal
Int J Radiat Oncol Biol Phys 58:903-13 (2004)
DOI:10.1016/j.ijrobp.2003.06.002
Reference
  Authors
DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.
  Title
Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.
  Journal
Oncogene 22:7781-95 (2003)
DOI:10.1038/sj.onc.1206966
Reference
  Authors
Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.
  Title
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.
  Journal
Oncogene 22:319-29 (2003)
DOI:10.1038/sj.onc.1206122
Reference
  Authors
Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.
  Title
Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.
  Journal
Cancer Lett 201:107-16 (2003)
DOI:10.1016/S0304-3835(03)00482-8
Reference
  Authors
Schmid RM.
  Title
Genetic basis of pancreatic cancer.
  Journal
Best Pract Res Clin Gastroenterol 16:421-33 (2002)
DOI:10.1053/bega.2002.0316
Reference
  Authors
Elliott RL, Blobe GC.
  Title
Role of transforming growth factor Beta in human cancer.
  Journal
J Clin Oncol 23:2078-93 (2005)
DOI:10.1200/JCO.2005.02.047
Reference
  Authors
Rudkin TM, Foulkes WD.
  Title
BRCA2: breaks, mistakes and failed separations.
  Journal
Trends Mol Med 11:145-8 (2005)
DOI:10.1016/j.molmed.2005.02.003
Reference
  Authors
Venkitaraman AR.
  Title
Functions of BRCA1 and BRCA2 in the biological response to DNA damage.
  Journal
J Cell Sci 114:3591-8 (2001)
Reference
  Authors
Soni D, King JA, Kaye AH, Hovens CM.
  Title
Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.
  Journal
J Clin Neurosci 12:1-5 (2005)
DOI:10.1016/j.jocn.2004.04.001
Reference
  Authors
Zhu Y, Parada LF.
  Title
The molecular and genetic basis of neurological tumours.
  Journal
Nat Rev Cancer 2:616-26 (2002)
DOI:10.1038/nrc866
Reference
  Authors
Holland EC.
  Title
Gliomagenesis: genetic alterations and mouse models.
  Journal
Nat Rev Genet 2:120-9 (2001)
DOI:10.1038/35052535
Reference
  Authors
Bansal K, Liang ML, Rutka JT.
  Title
Molecular biology of human gliomas.
  Journal
Technol Cancer Res Treat 5:185-94 (2006)
DOI:10.1177/153303460600500302
Reference
  Authors
Tabuchi K (ed).
  Title
[Gliomas: Research and therapy] (In Japanese)
  Journal
Springer-Verlag Tokyo (2006)
Reference
  Authors
Kapoor GS, O'Rourke DM.
  Title
Mitogenic signaling cascades in glial tumors.
  Journal
Neurosurgery 52:1425-34; discussion 1434-5 (2003)
DOI:10.1227/01.NEU.0000065135.28143.39
Reference
  Authors
Hulleman E, Helin K.
  Title
Molecular mechanisms in gliomagenesis.
  Journal
Adv Cancer Res 94:1-27 (2005)
DOI:10.1016/S0065-230X(05)94001-3
Reference
  Authors
Schlessinger J.
  Title
Cell signaling by receptor tyrosine kinases.
  Journal
Cell 103:211-25 (2000)
DOI:10.1016/S0092-8674(00)00114-8
Reference
PMID:9643506
  Authors
Ng HK, Lam PY.
  Title
The molecular genetics of central nervous system tumors.
  Journal
Pathology 30:196-202 (1998)
DOI:10.1080/00313029800169236
Reference
  Authors
Knobbe CB, Merlo A, Reifenberger G.
  Title
Pten signaling in gliomas.
  Journal
Neuro-oncol 4:196-211 (2002)
DOI:10.1093/neuonc/4.3.196
Reference
  Authors
Kondo T, Ezzat S, Asa SL.
  Title
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
  Journal
Nat Rev Cancer 6:292-306 (2006)
DOI:10.1038/nrc1836
Reference
  Authors
Chiloeches A, Marais R.
  Title
Is BRAF the Achilles' Heel of thyroid cancer?
  Journal
Clin Cancer Res 12:1661-4 (2006)
DOI:10.1158/1078-0432.CCR-06-0051
Reference
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
  Authors
Santoro M, Melillo RM, Fusco A.
  Title
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
  Journal
Eur J Endocrinol 155:645-653 (2006)
DOI:10.1530/eje.1.02289
Reference
  Authors
Pierotti MA, Greco A.
  Title
Oncogenic rearrangements of the NTRK1/NGF receptor.
  Journal
Cancer Lett 232:90-8 (2006)
DOI:10.1016/j.canlet.2005.07.043
Reference
  Authors
Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.
  Title
Molecular pathology of well-differentiated thyroid carcinomas.
  Journal
Virchows Arch 447:787-93 (2005)
DOI:10.1007/s00428-005-0065-5
Reference
  Authors
Gimm O.
  Title
Thyroid cancer.
  Journal
Cancer Lett 163:143-56 (2001)
DOI:10.1016/S0304-3835(00)00697-2
Reference
  Authors
Williams D.
  Title
Cancer after nuclear fallout: lessons from the Chernobyl accident.
  Journal
Nat Rev Cancer 2:543-9 (2002)
DOI:10.1038/nrc845
Reference
  Authors
Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.
  Title
The molecular pathogenesis of acute myeloid leukemia.
  Journal
Crit Rev Oncol Hematol 56:195-221 (2005)
DOI:10.1016/j.critrevonc.2004.10.012
Reference
  Authors
Tenen DG.
  Title
Disruption of differentiation in human cancer: AML shows the way.
  Journal
Nat Rev Cancer 3:89-101 (2003)
DOI:10.1038/nrc989
Reference
  Authors
Choudhary C, Muller-Tidow C, Berdel WE, Serve H.
  Title
Signal transduction of oncogenic Flt3.
  Journal
Int J Hematol 82:93-9 (2005)
DOI:10.1532/IJH97.05090
Reference
  Authors
Stirewalt DL, Radich JP.
  Title
The role of FLT3 in haematopoietic malignancies.
  Journal
Nat Rev Cancer 3:650-65 (2003)
DOI:10.1038/nrc1169
Reference
  Authors
Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C, Cocco L.
  Title
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.
  Journal
Leukemia 20:911-28 (2006)
DOI:10.1038/sj.leu.2404245
Reference
  Authors
Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.
  Title
Normal and oncogenic forms of the receptor tyrosine kinase kit.
  Journal
Stem Cells 23:16-43 (2005)
DOI:10.1634/stemcells.2004-0117
Reference
  Authors
Lorsbach RB, Downing JR.
  Title
The role of the AML1 transcription factor in leukemogenesis.
  Journal
Int J Hematol 74:258-65 (2001)
DOI:10.1007/BF02982058
Reference
  Authors
Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Bohmer FD, Muller-Tidow C, Berdel WE, Serve H.
  Title
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.
  Journal
Blood 101:3164-73 (2003)
DOI:10.1182/blood-2002-06-1677
Reference
  Authors
Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C.
  Title
The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.
  Journal
Leukemia 21:1638-47 (2007)
DOI:10.1038/sj.leu.2404732
Reference
  Authors
Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG.
  Title
ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
  Journal
Blood 107:3330-8 (2006)
DOI:10.1182/blood-2005-07-3068
Reference
  Authors
Ren R.
  Title
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.
  Journal
Nat Rev Cancer 5:172-83 (2005)
DOI:10.1038/nrc1567
Reference
  Authors
Deininger MW, Goldman JM, Melo JV.
  Title
The molecular biology of chronic myeloid leukemia.
  Journal
Blood 96:3343-56 (2000)
Reference
  Authors
Calabretta B, Perrotti D.
  Title
The biology of CML blast crisis.
  Journal
Blood 103:4010-22 (2004)
DOI:10.1182/blood-2003-12-4111
Reference
  Authors
Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM.
  Title
The biology of chronic myeloid leukemia.
  Journal
N Engl J Med 341:164-72 (1999)
DOI:10.1056/NEJM199907153410306
Reference
  Authors
Mitani K.
  Title
Molecular mechanisms of leukemogenesis by AML1/EVI-1.
  Journal
Oncogene 23:4263-9 (2004)
DOI:10.1038/sj.onc.1207777
Reference
  Authors
Dong M, Blobe GC.
  Title
Role of transforming growth factor-beta in hematologic malignancies.
  Journal
Blood 107:4589-96 (2006)
DOI:10.1182/blood-2005-10-4169
Reference
PMID:9834202
  Authors
Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H.
  Title
The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
  Journal
Blood 92:4003-12 (1998)
Reference
  Authors
Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA.
  Title
p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.
  Journal
Haematologica 88:622-30 (2003)
Reference
  Authors
Baldwin AS.
  Title
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
  Journal
J Clin Invest 107:241-6 (2001)
DOI:10.1172/JCI11991
Reference
  Authors
Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL.
  Title
PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
  Journal
Nat Med 8:1145-52 (2002)
DOI:10.1038/nm759
Reference
  Authors
Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC.
  Title
Molecular aetiology and pathogenesis of basal cell carcinoma.
  Journal
Br J Dermatol 152:1108-24 (2005)
DOI:10.1111/j.1365-2133.2005.06587.x
Reference
  Authors
Saldanha G, Fletcher A, Slater DN.
  Title
Basal cell carcinoma: a dermatopathological and molecular biological update.
  Journal
Br J Dermatol 148:195-202 (2003)
DOI:10.1046/j.1365-2133.2003.05151.x
Reference
  Authors
Daya-Grosjean L, Couve-Privat S.
  Title
Sonic hedgehog signaling in basal cell carcinomas.
  Journal
Cancer Lett 225:181-92 (2005)
DOI:10.1016/j.canlet.2004.10.003
Reference
  Authors
Tsai KY, Tsao H.
  Title
The genetics of skin cancer.
  Journal
Am J Med Genet C Semin Med Genet 131C:82-92 (2004)
DOI:10.1002/ajmg.c.30037
Reference
  Authors
Athar M, Tang X, Lee JL, Kopelovich L, Kim AL.
  Title
Hedgehog signalling in skin development and cancer.
  Journal
Exp Dermatol 15:667-77 (2006)
DOI:10.1111/j.1600-0625.2006.00473.x
Reference
  Authors
Rubin AI, Chen EH, Ratner D.
  Title
Basal-cell carcinoma.
  Journal
N Engl J Med 353:2262-9 (2005)
DOI:10.1056/NEJMra044151
Reference
  Authors
Saldanha G.
  Title
The Hedgehog signalling pathway and cancer.
  Journal
Reference
  Authors
Saldanha G, Ghura V, Potter L, Fletcher A.
  Title
Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.
  Journal
Br J Dermatol 151:157-64 (2004)
DOI:10.1111/j.1365-2133.2004.06048.x
Reference
  Authors
Pasca di Magliano M, Hebrok M.
  Title
Hedgehog signalling in cancer formation and maintenance.
  Journal
Nat Rev Cancer 3:903-11 (2003)
DOI:10.1038/nrc1229
Reference
  Authors
Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.
  Title
Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
  Journal
Br J Dermatol 152:43-51 (2005)
DOI:10.1111/j.1365-2133.2005.06353.x
Reference
  Authors
Cohen MM Jr.
  Title
The hedgehog signaling network.
  Journal
Am J Med Genet A 123:5-28 (2003)
DOI:10.1002/ajmg.a.20495
Reference
  Authors
Yamazaki F, Aragane Y, Kawada A, Tezuka T.
  Title
Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.
  Journal
Br J Dermatol 145:771-7 (2001)
DOI:10.1046/j.1365-2133.2001.04468.x
Reference
  Authors
Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA.
  Title
Role of apoptosis in basal cell and squamous cell carcinoma formation.
  Journal
Immunol Lett 100:68-72 (2005)
DOI:10.1016/j.imlet.2005.06.008
Reference
  Authors
Toftgard R.
  Title
Hedgehog signalling in cancer.
  Journal
Cell Mol Life Sci 57:1720-31 (2000)
DOI:10.1007/PL00000654
Reference
  Authors
Miller AJ, Mihm MC Jr.
  Title
Melanoma.
  Journal
N Engl J Med 355:51-65 (2006)
DOI:10.1056/NEJMra052166
Reference
  Authors
Chin L.
  Title
The genetics of malignant melanoma: lessons from mouse and man.
  Journal
Nat Rev Cancer 3:559-70 (2003)
DOI:10.1038/nrc1145
Reference
  Authors
Takata M, Saida T.
  Title
Genetic alterations in melanocytic tumors.
  Journal
J Dermatol Sci 43:1-10 (2006)
DOI:10.1016/j.jdermsci.2006.05.002
Reference
  Authors
Chudnovsky Y, Khavari PA, Adams AE.
  Title
Melanoma genetics and the development of rational therapeutics.
  Journal
J Clin Invest 115:813-24 (2005)
DOI:10.1172/JCI24808
Reference
  Authors
Merlino G.
  Title
Cancer biology: the weakest link?
  Journal
Nature 436:33-5 (2005)
DOI:10.1038/436033a
Reference
  Authors
Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.
  Title
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
  Journal
Nature 436:117-22 (2005)
DOI:10.1038/nature03664
Reference
  Authors
Levy C, Khaled M, Fisher DE.
  Title
MITF: master regulator of melanocyte development and melanoma oncogene.
  Journal
Trends Mol Med 12:406-14 (2006)
DOI:10.1016/j.molmed.2006.07.008
Reference
  Authors
Tsao H, Goel V, Wu H, Yang G, Haluska FG.
  Title
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
  Journal
J Invest Dermatol 122:337-41 (2004)
DOI:10.1046/j.0022-202X.2004.22243.x
Reference
  Authors
Gruss C, Herlyn M.
  Title
Role of cadherins and matrixins in melanoma.
  Journal
Curr Opin Oncol 13:117-23 (2001)
DOI:10.1097/00001622-200103000-00006
Reference
  Authors
Thompson JF, Scolyer RA, Kefford RF.
  Title
Cutaneous melanoma.
  Journal
Lancet 365:687-701 (2005)
DOI:10.1016/S0140-6736(05)17951-3
Reference
  Authors
Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.
  Title
NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.
  Journal
Clin Cancer Res 9:6483-8 (2003)
Reference
  Authors
Hussein MR.
  Title
The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?
  Journal
Tumour Biol 25:200-7 (2004)
DOI:10.1159/000081103
Reference
  Authors
Lazar-Molnar E, Hegyesi H, Toth S, Falus A.
  Title
Autocrine and paracrine regulation by cytokines and growth factors in melanoma.
  Journal
Cytokine 12:547-54 (2000)
DOI:10.1006/cyto.1999.0614
Reference
  Authors
Cohen HT, McGovern FJ.
  Title
Renal-cell carcinoma.
  Journal
N Engl J Med 353:2477-90 (2005)
DOI:10.1056/NEJMra043172
Reference
  Authors
Pavlovich CP, Schmidt LS.
  Title
Searching for the hereditary causes of renal-cell carcinoma.
  Journal
Nat Rev Cancer 4:381-93 (2004)
DOI:10.1038/nrc1364
Reference
  Authors
Linehan WM, Walther MM, Zbar B.
  Title
The genetic basis of cancer of the kidney.
  Journal
J Urol 170:2163-72 (2003)
DOI:10.1097/01.ju.0000096060.92397.ed
Reference
  Authors
Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.
  Title
Met, metastasis, motility and more.
  Journal
Nat Rev Mol Cell Biol 4:915-25 (2003)
DOI:10.1038/nrm1261
Reference
  Authors
Kim WY, Kaelin WG.
  Title
Role of VHL gene mutation in human cancer.
  Journal
J Clin Oncol 22:4991-5004 (2004)
DOI:10.1200/JCO.2004.05.061
Reference
  Authors
Sudarshan S, Linehan WM, Neckers L.
  Title
HIF and fumarate hydratase in renal cancer.
  Journal
Br J Cancer 96:403-7 (2007)
DOI:10.1038/sj.bjc.6603547
Reference
  Authors
Sudarshan S, Pinto PA, Neckers L, Linehan WM.
  Title
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.
  Journal
Nat Clin Pract Urol 4:104-10 (2007)
DOI:10.1038/ncpuro0711
Reference
  Authors
Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.
  Title
Understanding familial and non-familial renal cell cancer.
  Journal
Hum Mol Genet 11:2489-98 (2002)
DOI:10.1093/hmg/11.20.2489
Reference
  Authors
Mitra AP, Datar RH, Cote RJ.
  Title
Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.
  Journal
J Clin Oncol 24:5552-64 (2006)
DOI:10.1200/JCO.2006.08.2073
Reference
  Authors
Wolff EM, Liang G, Jones PA.
  Title
Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.
  Journal
Nat Clin Pract Urol 2:502-10 (2005)
DOI:10.1038/ncpuro0318
Reference
  Authors
Wu XR.
  Title
Urothelial tumorigenesis: a tale of divergent pathways.
  Journal
Nat Rev Cancer 5:713-25 (2005)
DOI:10.1038/nrc1697
Reference
  Authors
Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R.
  Title
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.
  Journal
Cancer Res 60:6298-302 (2000)
Reference
  Authors
Bellmunt J, Hussain M, Dinney CP.
  Title
Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.
  Journal
Crit Rev Oncol Hematol 46 Suppl:S85-104 (2003)
DOI:10.1016/S1040-8428(03)00067-2
Reference
  Authors
Sugano K, Kakizoe T.
  Title
Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
  Journal
Nat Clin Pract Urol 3:642-52 (2006)
DOI:10.1038/ncpuro0649
Reference
  Authors
Dunn KL, Espino PS, Drobic B, He S, Davie JR.
  Title
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
  Journal
Biochem Cell Biol 83:1-14 (2005)
DOI:10.1139/o04-121
Reference
  Authors
Williams SG, Stein JP.
  Title
Molecular pathways in bladder cancer.
  Journal
Urol Res 32:373-85 (2004)
DOI:10.1007/s00240-003-0345-y
Reference
  Authors
Nelson WG, De Marzo AM, Isaacs WB.
  Title
Prostate cancer.
  Journal
N Engl J Med 349:366-81 (2003)
DOI:10.1056/NEJMra021562
Reference
  Authors
Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.
  Title
The emerging role of the PI3-K-Akt pathway in prostate cancer progression.
  Journal
Prostate Cancer Prostatic Dis 8:108-18 (2005)
DOI:10.1038/sj.pcan.4500776
Reference
  Authors
Pienta KJ, Bradley D.
  Title
Mechanisms underlying the development of androgen-independent prostate cancer.
  Journal
Clin Cancer Res 12:1665-71 (2006)
DOI:10.1158/1078-0432.CCR-06-0067
Reference
  Authors
Feldman BJ, Feldman D.
  Title
The development of androgen-independent prostate cancer.
  Journal
Nat Rev Cancer 1:34-45 (2001)
DOI:10.1038/35094009
Reference
  Authors
Heinlein CA, Chang C.
  Title
Androgen receptor in prostate cancer.
  Journal
Endocr Rev 25:276-308 (2004)
DOI:10.1210/er.2002-0032
Reference
PMID:9422516
  Authors
Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP.
  Title
Androgen receptor gene and hormonal therapy failure of prostate cancer.
  Journal
Am J Pathol 152:1-9 (1998)
Reference
  Authors
Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.
  Title
Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.
  Journal
Nat Med 6:703-6 (2000)
DOI:10.1038/76287
Reference
  Authors
Macri E, Loda M.
  Title
Role of p27 in prostate carcinogenesis.
  Journal
Cancer Metastasis Rev 17:337-44 (1998)
DOI:10.1023/A:1006133620914
Reference
  Authors
Steers WD.
  Title
5alpha-reductase activity in the prostate.
  Journal
Urology 58:17-24; discussion 24 (2001)
DOI:10.1016/S0090-4295(01)01299-7
Reference
PMID:8069858
  Authors
Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF.
  Title
Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.
  Journal
Cancer Res 54:4920-6 (1994)
Reference
  Authors
Grimes CA, Jope RS.
  Title
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.
  Journal
Prog Neurobiol 65:391-426 (2001)
DOI:10.1016/S0301-0082(01)00011-9
Reference
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Reference
  Authors
Sanchez-Cespedes M.
  Title
Dissecting the genetic alterations involved in lung carcinogenesis.
  Journal
Lung Cancer 40:111-21 (2003)
DOI:10.1016/S0169-5002(03)00033-3
Reference
  Authors
Kaye FJ.
  Title
Molecular biology of lung cancer.
  Journal
Lung Cancer 34 Suppl 2:S35-41 (2001)
DOI:10.1016/S0169-5002(01)00342-7
Reference
  Authors
Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF.
  Title
Apoptosis and lung cancer: a review.
  Journal
J Cell Biochem 88:885-98 (2003)
DOI:10.1002/jcb.10440
Reference
  Authors
Sartorius UA, Krammer PH.
  Title
Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.
  Journal
Int J Cancer 97:584-92 (2002)
DOI:10.1002/ijc.10096
Reference
  Authors
Adhikary S, Eilers M.
  Title
Transcriptional regulation and transformation by Myc proteins.
  Journal
Nat Rev Mol Cell Biol 6:635-45 (2005)
DOI:10.1038/nrm1703
Reference
  Authors
Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI.
  Title
A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.
  Journal
Mol Cell 7:639-50 (2001)
DOI:10.1016/S1097-2765(01)00210-6
Reference
  Authors
Buttery RC, Rintoul RC, Sethi T.
  Title
Small cell lung cancer: the importance of the extracellular matrix.
  Journal
Int J Biochem Cell Biol 36:1154-60 (2004)
DOI:10.1016/S1357-2725(03)00261-9
Reference
  Authors
Yamada KM, Araki M.
  Title
Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.
  Journal
J Cell Sci 114:2375-82 (2001)
Reference
  Authors
Rintoul RC, Sethi T.
  Title
The role of extracellular matrix in small-cell lung cancer.
  Journal
Lancet Oncol 2:437-42 (2001)
DOI:10.1016/S1470-2045(00)00421-6
Reference
  Authors
Ekedahl J, Joseph B, Grigoriev MY, Muller M, Magnusson C, Lewensohn R, Zhivotovsky B.
  Title
Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.
  Journal
Exp Cell Res 279:277-90 (2002)
DOI:10.1006/excr.2002.5608
Reference
  Authors
Osada H, Takahashi T.
  Title
Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
  Journal
Oncogene 21:7421-34 (2002)
DOI:10.1038/sj.onc.1205802
Reference
  Authors
Yokota J, Nishioka M, Tani M, Kohno T.
  Title
Genetic alterations responsible for metastatic phenotypes of lung cancer cells.
  Journal
Clin Exp Metastasis 20:189-93 (2003)
DOI:10.1023/a:1022978932215
Reference
  Authors
Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS.
  Title
K-ras mutations in non-small-cell lung carcinoma: a review.
  Journal
Clin Lung Cancer 8:30-8 (2006)
DOI:10.3816/CLC.2006.n.030
Reference
  Authors
Pfeifer GP, Dammann R.
  Title
Methylation of the tumor suppressor gene RASSF1A in human tumors.
  Journal
Biochemistry (Mosc) 70:576-83 (2005)
DOI:10.1007/s10541-005-0151-y
Reference
  Authors
Altucci L, Gronemeyer H.
  Title
The promise of retinoids to fight against cancer.
  Journal
Nat Rev Cancer 1:181-93 (2001)
DOI:10.1038/35106036
Reference
  Authors
Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.
  Title
Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.
  Journal
J Natl Cancer Inst 92:1303-7 (2000)
DOI:10.1093/jnci/92.16.1303
Reference
  Authors
Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA.
  Title
Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.
  Journal
Lung Cancer 41 Suppl 1:S29-42 (2003)
DOI:10.1016/S0169-5002(03)00137-5
Reference
  Authors
Panani AD, Roussos C.
  Title
Cytogenetic and molecular aspects of lung cancer.
  Journal
Cancer Lett 239:1-9 (2006)
DOI:10.1016/j.canlet.2005.06.030
Reference
  Authors
Mitsuuchi Y, Testa JR.
  Title
Cytogenetics and molecular genetics of lung cancer.
  Journal
Am J Med Genet 115:183-8 (2002)
DOI:10.1002/ajmg.10692
Reference
  Authors
Breuer RH, Postmus PE, Smit EF.
  Title
Molecular pathology of non-small-cell lung cancer.
  Journal
Respiration 72:313-30 (2005)
DOI:10.1159/000085376
Reference
  Authors
Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC, Grizzle WE.
  Title
Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
  Journal
Clin Cancer Res 8:734-44 (2002)
Reference
  Authors
Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.
  Title
Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
  Journal
J Clin Pathol 58:1076-80 (2005)
DOI:10.1136/jcp.2004.025585
Reference
  Authors
Lappano R, Maggiolini M
  Title
G protein-coupled receptors: novel targets for drug discovery in cancer.
  Journal
Nat Rev Drug Discov 10:47-60 (2011)
DOI:10.1038/nrd3320
Reference
  Authors
O'Hayre M, Degese MS, Gutkind JS
  Title
Novel insights into G protein and G protein-coupled receptor signaling in cancer.
  Journal
Curr Opin Cell Biol 27:126-35 (2014)
DOI:10.1016/j.ceb.2014.01.005
Reference
  Authors
Dorsam RT, Gutkind JS
  Title
G-protein-coupled receptors and cancer.
  Journal
Nat Rev Cancer 7:79-94 (2007)
DOI:10.1038/nrc2069
Related
pathway
lruf03320  PPAR signaling pathway
lruf04010  MAPK signaling pathway
lruf04020  Calcium signaling pathway
lruf04024  cAMP signaling pathway
lruf04060  Cytokine-cytokine receptor interaction
lruf04066  HIF-1 signaling pathway
lruf04110  Cell cycle
lruf04115  p53 signaling pathway
lruf04150  mTOR signaling pathway
lruf04151  PI3K-Akt signaling pathway
lruf04210  Apoptosis
lruf04310  Wnt signaling pathway
lruf04330  Notch signaling pathway
lruf04340  Hedgehog signaling pathway
lruf04350  TGF-beta signaling pathway
lruf04370  VEGF signaling pathway
lruf04510  Focal adhesion
lruf04512  ECM-receptor interaction
lruf04520  Adherens junction
lruf04630  JAK-STAT signaling pathway
lruf04915  Estrogen signaling pathway
KO pathway
ko05200   
LinkDB

DBGET integrated database retrieval system